TEXAGEN® Amniotic Membrane Allograft provides protection & support through amniotic tissue
TEXAGEN® Amniotic Membrane Allograft is a multilayer
amniotic membrane that may be used as a soft tissue barrier
and wound covering in numerous applications.
Cover with Confidence
- Flexible multilayer allograft
- Derived from the amnion and chorion layers of the amniotic sac
- Approximately 4x thicker than traditional single layer amnion
- Flexible handling and increased workability
Safety and Versatility
- The inherent properties of amniotic tissue harness growth factors essential for supporting damaged tissue and providing mechanical protection. 1,2
- The TEXAGEN process preserves the inherent properties of amniotic tissue, maintaining key extracellular matrix molecules, growth factors, and cytokines.3
- Handled and processed in accordance with FDA regulations and AATB standards
Designed for Convenience
- Requires no up-front preparation
- Hydrates rapidly in the surgical site
- Ambient temperature storage and 5-year shelf life
Used in multiple clinical applications
Wound and
Burn Care
Urology
OB/GYN
Oral Surgery
Spine and
Neurosurgery
Orthopaedics
Foot
and Ankle
References
1. Rowlatt, U. (1979). Intrauterine wound healing in a 20-week human fetus.
Virchows Arch A Pathol Anat Histol, 381(3), 353–361.
2. Coolen, N.A et al. (2010). Comparison between human fetal and adult skin. Archives of
Dermatological Research, 302(1),47-55.
3.Delcroix GJ, Namin S, D’Ippolito G, Temple HT, Marshall R. Preserving the natural regenerative potential of
amniotic membrane. Vivex Biologics, Inc.
"*" indicates required fields
Keep Up With the Latest Developments
in Surgical and Wound Care Technology
Sign Up for the Sanara MedTech Mailing List
Most Recent Press Releases
Sanara MedTech Inc. Reports Third Quarter 2024 Results
November 13, 2024Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates
November 4, 2024Sanara MedTech Inc. Announces Changes to Its Board of Directors
October 7, 2024